Commentary
Advances in breast cancer treatment and prevention: preclinical studies on aromatase inhibitors and new selective estrogen receptor modulators (SERMs)
-
* Corresponding author: Rachel Schiff rschiff@breastcenter.tmc.edu
Breast Cancer Res 2003, 5:228-231 doi:10.1186/bcr626
No comments have yet been made on this article.